Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $252.55 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $187.87 | 10 | $0 (2023) |
| Incyte Corporation | $24.70 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $23.49 | 1 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $16.49 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $54.34 | 2 | ABBVIE INC. ($30.85) |
| 2022 | $181.72 | 10 | ABBVIE INC. ($157.02) |
| 2020 | $16.49 | 1 | Sun Pharmaceutical Industries Inc. ($16.49) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Dermatology | ||||||
| 10/27/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2022 | ABBVIE INC. | RINVOQ (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.70 | General |
| Category: Dermatology | ||||||
| 07/25/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: IMMUNOLOGY | ||||||
| 07/07/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: IMMUNOLOGY | ||||||
| 02/14/2022 | ABBVIE INC. | RINVOQ (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2022 | ABBVIE INC. | RINVOQ (Biological), RINVOQ | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2020 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug), CEQUA, XELPROS | Food and Beverage | Cash or cash equivalent | $16.49 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 970 | 1,413 | $227,660 | $39,973 |
| 2022 | 15 | 2,791 | 5,175 | $857,536 | $186,142 |
| 2021 | 27 | 5,749 | 11,097 | $953,402 | $437,514 |
| 2020 | 27 | 5,353 | 9,943 | $750,090 | $363,420 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 320 | 344 | $92,809 | $15,224 | 16.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 225 | 243 | $49,109 | $7,970 | 16.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 69 | 73 | $22,432 | $5,064 | 22.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 71 | 73 | $25,041 | $4,824 | 19.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 163 | 549 | $11,109 | $2,477 | 22.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 74 | 75 | $12,649 | $1,723 | 13.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 20 | 27 | $4,104 | $1,100 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 15 | $5,738 | $946.65 | 16.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $4,668 | $646.05 | 13.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 850 | 1,271 | $346,830 | $75,160 | 21.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 615 | 905 | $184,240 | $36,856 | 20.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 220 | 253 | $87,505 | $20,142 | 23.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 195 | 231 | $72,349 | $15,453 | 21.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 459 | 2,000 | $41,520 | $10,026 | 24.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 234 | 269 | $45,644 | $9,944 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 46 | $17,751 | $4,390 | 24.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 30 | 32 | $17,376 | $4,375 | 25.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 51 | 51 | $17,101 | $3,408 | 19.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2022 | 11 | 12 | $6,881 | $1,857 | 27.0% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 12 | 12 | $7,484 | $1,841 | 24.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 31 | 37 | $5,770 | $1,401 | 24.3% |
| 69100 | Biopsy of ear | Office | 2022 | 11 | 11 | $3,245 | $671.62 | 20.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $3,063 | $592.26 | 19.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 14 | 31 | $775.00 | $26.15 | 3.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 1,373 | 2,172 | $258,518 | $130,167 | 50.4% |
About Dr. John Miller, MD
Dr. John Miller, MD is a Dermatology healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831250711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Miller, MD has received a total of $252.55 in payments from pharmaceutical and medical device companies, with $54.34 received in 2023. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($252.55).
As a Medicare-enrolled provider, Miller has provided services to 14,863 Medicare beneficiaries, totaling 27,628 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Bedford, TX
- Active Since 12/13/2006
- Last Updated 02/14/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1831250711
Products in Payments
- SKYRIZI (Biological) $111.54
- RINVOQ (Biological) $49.40
- HUMIRA (Biological) $26.93
- OPZELURA (Drug) $24.70
- COSENTYX (Drug) $23.49
- BROMSITE (Drug) $16.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Bedford
Calvin Williams, M.d, M.D
Dermatology — Payments: $53,464
Jennifer Stead, D.o, D.O
Dermatology — Payments: $28,261
Dr. Christopher Fuller, M.d, M.D
Dermatology — Payments: $22,284
Molly Cowdrey, M.d, M.D
Dermatology — Payments: $4,916
Shaun Cooper, Md, MD
Dermatology — Payments: $4,235
Dr. Jorge Roman, M.d, M.D
Dermatology — Payments: $3,994